March 10, 2015
March 10, 2015 —
…Affairs San Diego Healthcare System and University of California, San Diego School of Medicine, with colleagues in New York and the United Kingdom, have identified genetic markers, derived from blood samples that are linked to post-traumatic stress disorder (PTSD). The markers are associated with gene networks that regulate innate immune…
September 17, 2019
September 17, 2019 —
Researchers at the University of California San Diego figured out a way to combine FDA-approved ultrasound with engineered glass particles to boost the effectiveness of immunotherapy in glioblastomas.
December 28, 2022
December 28, 2022 —
UC San Diego study reveals critical insights into the complex biology of tissue-specific T cells, paving the way for a new branch of precision therapeutics in immunity, autoimmunity, and cancer.
May 4, 2016
May 4, 2016 —
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
September 19, 2014
September 19, 2014 —
Researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.
April 25, 2017
April 25, 2017 —
Nanoengineering professor Liangfang Zhang at the University of California San Diego has been selected as the U.S. nominee for the APEC Science Prize for Innovation, Research and Education (ASPIRE). Zhang won the nomination for his revolutionary work in the field of nanomedicine, which focuses on nanomaterials for medical applications.
June 11, 2020
June 11, 2020 —
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
May 21, 2021
May 21, 2021 —
UC San Diego School of Medicine researchers identify how the body regulates and prevents constant skin inflammation.
November 23, 2020
November 23, 2020 —
Researchers have identified the first key biological switch that sounds an alarm in plants when plant-eating animals attack. The mechanism will help unlock a trove of new strategies for improved plant health, from countering crop pest damage to engineering more robust global food webs.
June 11, 2021
June 11, 2021 —
UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.